Clinical trial
Dose Escalation Study of SH U04722 in Solid Tumors
NCT00375453 · Bayer, Industry · Terminated
Key facts
| NCT number | NCT00375453 |
|---|---|
| Title | Dose Escalation Study of SH U04722 in Solid Tumors |
| Official title | Phase I, Open-label, Dose Escalation Study for Evaluation of Safety, Tolerability, Pharmacokinetics, and Tumor-suppressive Efficacy of SH U04722 in Patients With Solid Tumors |
| Lead sponsor | Bayer, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | SH U04722 |
| Enrollment | 10 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 13, 2006 |
| Last update posted | Dec 31, 2014 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: